These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12112937)

  • 1. Insulin resistance in type 1 diabetes.
    Greenbaum CJ
    Diabetes Metab Res Rev; 2002; 18(3):192-200. PubMed ID: 12112937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From insulin secretion to insulin therapy].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
    [No Abstract]   [Full Text] [Related]  

  • 4. Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 9 [corrected].
    Juhl CB; Bradley U; Holst JJ; Leslie RD; Yderstraede KB; Hunter S;
    Diabet Med; 2014 Aug; 31(8):941-5. PubMed ID: 24628669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic impact of puberty on the course of type 1 diabetes.
    Acerini CL; Williams RM; Dunger DB
    Diabetes Metab; 2001 Sep; 27(4 Pt 2):S19-25. PubMed ID: 11787432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of randomised controlled trials of the effects of caffeine or caffeinated drinks on blood glucose concentrations and insulin sensitivity in people with diabetes mellitus.
    Whitehead N; White H
    J Hum Nutr Diet; 2013 Apr; 26(2):111-25. PubMed ID: 23331476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiological basis for intensive insulin replacement.
    Rolla A
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S3-7. PubMed ID: 15306831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic syndrome, type 1 diabetes mellitus and insulin resistance].
    Chillarón JJ; Goday A; Pedro-Botet J
    Med Clin (Barc); 2008 Apr; 130(12):466-70. PubMed ID: 18405504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance is associated with microangiopathy in type 1 diabetic patients treated with intensive insulin therapy from the onset of disease.
    Uruska A; Araszkiewicz A; Zozulinska-Ziolkiewicz D; Uruski P; Wierusz-Wysocka B
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):478-84. PubMed ID: 20373280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The natural history of diabetes with respect to disorders of insulin function].
    Dorner M; Pinget M; Brogard JM; Sapin R; Paris-Bockel D; Levy P; Jung C
    Journ Annu Diabetol Hotel Dieu; 1984; ():51-71. PubMed ID: 6399540
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiology of glucose homeostasis and insulin therapy in type 1 and type 2 diabetes.
    Ferrannini E
    Endocrinol Metab Clin North Am; 2012 Mar; 41(1):25-39. PubMed ID: 22575405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance, role of metformin and other non-insulin therapies in pediatric type 1 diabetes.
    Bacha F; Klinepeter Bartz S
    Pediatr Diabetes; 2016 Dec; 17(8):545-558. PubMed ID: 26592507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
    Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
    Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Strategies for Inducing Glycemic Remission during the Honeymoon Phase of Type 2 Diabetes.
    Retnakaran R
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S142-7. PubMed ID: 26653254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of Prosopis glandulosa as antidiabetic treatment in rat models of diabetes and insulin resistance.
    George C; Lochner A; Huisamen B
    J Ethnopharmacol; 2011 Sep; 137(1):298-304. PubMed ID: 21645608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.